entertainment -WSS

entertainment

author：leisure time 2025-10-01 14:20:16 - browse：35

Sammy Kimball for STAT

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss what some recent layoffs and a reverse merger mean for biotech in 2023. We’ll also discuss the latest news in the life sciences, including a dramatic saga in ocular medicine, the volatile business of Covid-19, and some major milestones in gene therapy.

For more on what we cover, here’s the news on Celsius Therapeutics; here’s more on EQRx; here’s the latest on Apellis Pharmaceuticals; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： The high cost of giving birth even with insurance
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

knowledge

explore

WSS

What should King Charles tell the public about his cancer?

Google says AlphaFold 3 can map a vast universe of biomolecules

Bird flu outbreak in cows is latest avian flu curveball

KalVista pill reduced swelling 'attacks' caused by genetic disease

Medicare threatens to cut off funding for HCA's Mission hospital

H5N1 bird flu: what we're starting to learn about infection in cows

entertainment

entertainment

knowledge

Activists slam private health insurers over coverage restrictions

The dental labor crisis is a moment of opportunity

Medical leaders decry Supreme Court decision on affirmative action

Medicare says breakthrough device reimbursement rule to come by summer

Walensky prepares to leave CDC — and Congress — behind

Private equity deals in Medicare Advantage declines

After affirmative action ruling, medical educators look to 'holistic review'

Medical mystery: When a cough is not just a cough

Moonlake's readout produced a cash windfall. Risks remain

Elevance, private equity launch primary care company

knowledge

Medicare says breakthrough device reimbursement rule to come by summer

Shionogi licenses Pompe disease therapy from Maze Therapeutics

For Medicare Advantage, Democrats want stronger protections around AI

How digital tools helped lower hypertension in marginalized patients

Readout LOUD podcast: brain research, obesity drug sales, Novartis

To avoid data mishandling cases, universities eye AI and other tools

focus

knowledge

explore

explore